Updated Date:
17 Nov 2025
Product Detail:
Pfizer (Australia) TOBRAMYCIN (as sulfate) PF 80 mg/2 mL injection ampoule
Shortage Status:
Anticipated
AUST R:
10776
Availability:
Available
Active Ingredient:
tobramycin
Reason:
Manufacturing
Dosage Form:
Injection,solution
Supply Impact Dates
From 08 Dec 2025
To 27 Feb 2026
Management Action:
Sponsor is closely controlling the supply. Alternative brands are available. An overseas registered product has been approved for supply under Section 19A. The approval holder, ORSPEC Pharma Pty Ltd, can be contacted for details on supply on 02 4339 4239.
